$14.110
+2.426 (+17.19%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
HCM 相似圖表分析預測
Alphio's HCM stock price prediction model matches the current HUTCHMED (China) Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $14.10 (-0.06%). The 1-week path is $13.83 (-2.00%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 HUTCHMED (China) Ltd 股票嗎？
HUTCHMED (China) Ltd is a good buy right now, primarily driven by its recent conditional approval for Fanregratinib, which is expected to enhance revenue growth. The current price is $12.38, and the forward P/E ratio is 14.41, indicating a more favorable valuation compared to its historical performance. Additionally, the stock has shown a 20-day change of +11.23%, suggesting positive momentum. However, the main risk is its high P/E ratio of 1103.79, which indicates potential overvaluation if future earnings do not meet expectations.
HCM 股價於 Thursday 收在 $14.11，此前上漲 +17.19%
HUTCHMED (China) Ltd (HCM) last closed at $14.11, gaining +17.19%. These facts feed the 1-day and 1-week HCM price prediction above.
分析師一致預期
HUTCHMED (China) Ltd（HCM）：買進 4、持有 0、賣出 0。展望：Strong Buy。
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
預測驅動因素
HUTCHMED (China) Ltd（HCM）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
相似圖表形態
近期走勢與 HCM 最接近的股票，依相似度排序。
HCM 季節性分析
Historically the probability of a positive September return for HCM is 56.82%. October offers the highest probability of a positive month at 82.61%, while December is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。